About Brain Therapeutics
Brain Therapeutics was founded in 2012 as a standalone neurology clinic based in Athens, Greece. Neurological diagnostics and treatments are delivered to patients with brain and nervous system disorders. The clinic is overseen by George Pavlakis as Managing Director. Independent operations are maintained without ties to broader healthcare systems. The website braintherapeutics.gr is maintained for patient information and appointments.
- Headquarter Athens, Greece
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Neuraxpharm
(Mar 08, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Brain Therapeutics
Detailed funding history for Brain Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Brain Therapeutics
Brain Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Neuraxpharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CNS drugs and treatments are developed and commercialized by Neuraxpharm.
|
Locked | Locked | Locked |
Investor details for Brain Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brain Therapeutics
Investment portfolio details for Brain Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brain Therapeutics
Detailed financials for Brain Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brain Therapeutics Comparisons
Peer comparison for Brain Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brain Therapeutics
Detailed competitors of Brain Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brain Therapeutics
Complete news archive for Brain Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brain Therapeutics
Brain Therapeutics was founded in 2012.
Brain Therapeutics is headquartered in Athens, Greece.
Brain Therapeutics was founded in 2012 as a standalone neurology clinic based in Athens, Greece. Neurological diagnostics and treatments are delivered to patients with brain and nervous system disorders. The clinic is overseen by George Pavlakis as Managing Director. Independent operations are maintained without ties to broader healthcare systems. The website braintherapeutics.gr is maintained for patient information and appointments.
Brain Therapeutics has 1 investor. Key investors include Neuraxpharm.